RPG Life Sciences Limited (RPGLIFE.BO)
INR 2228.1
(1.76%)
INR 2228.1
(1.76%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 953.3 Million | 908.2 Million | 647.5 Million | 582.7 Million | 501.7 Million | 457.8 Million |
| Net Income | 876.6 Million | 916.8 Million | 731.7 Million | 535.8 Million | 364.5 Million | 150.5 Million |
| Depreciation & Amortization | 170.7 Million | 155 Million | 156.6 Million | 164.7 Million | 163.6 Million | 153.2 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -70.9 Million | 110.5 Million | -31.1 Million | -35.3 Million | -23.7 Million | 143.7 Million |
| Other non-cash items | 456.8 Million | -274.1 Million | -209.7 Million | -82.5 Million | -2.7 Million | 10.4 Million |
| Investing Cash Flow | -805.7 Million | -1.05 Billion | -346.6 Million | -79.6 Million | -107 Million | -190.2 Million |
| Investments in PPE | -692.3 Million | -327.3 Million | -239.5 Million | -85.1 Million | -107.4 Million | -196.8 Million |
| Acquisitions | 1.5 Million | 800 Thousand | 13.3 Million | 500 Thousand | 400 Thousand | 1.1 Million |
| Investment purchases | -445.1 Million | -569.9 Million | -128.6 Million | 1.4 Million | -1.7 Million | - |
| Sales/Maturities of investments | 330.2 Million | 27.3 Million | 8.9 Million | 1.8 Million | 3.4 Million | - |
| Other Investing Activities | 154.7 Million | -189 Million | -700 Thousand | 1.8 Million | -1.7 Million | 5.5 Million |
| Financing Cash Flow | -198.6 Million | -171.2 Million | -135.1 Million | -104.9 Million | -393 Million | -265 Million |
| Debt repayment | -100 Thousand | -2.7 Million | -4.2 Million | -90.7 Million | -2.1 Million | -119.5 Million |
| Dividends payments | -198.5 Million | -158.8 Million | -119.1 Million | - | -127.7 Million | -47.9 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -4.5 Million | -9.7 Million | -11.8 Million | -14.2 Million | -263.2 Million | -97.6 Million |
| Accounts receivables | -142.3 Million | -54 Million | 248.1 Million | 62.2 Million | -235.9 Million | 285.7 Million |
| Accounts payables | 63.3 Million | 192.6 Million | -19.1 Million | 31.2 Million | 193.3 Million | -267.3 Million |
| Inventory | -59.5 Million | -120.6 Million | -246.6 Million | -117.2 Million | -55.7 Million | 126.5 Million |
| Other working capital | 67.6 Million | 92.5 Million | -13.5 Million | -11.5 Million | 74.6 Million | -1.2 Million |
| Cash at beginning of period | 254.9 Million | 569.4 Million | 403.6 Million | 5.4 Million | 3.7 Million | 1.1 Million |
| Cash at end of period | 364.7 Million | 248.2 Million | 569.4 Million | 403.6 Million | 5.4 Million | 3.7 Million |
| Capital Expenditure | -692.3 Million | -327.3 Million | -239.5 Million | -85.1 Million | -107.4 Million | -196.8 Million |
| Effect of forex changes on cash | - | -100 Thousand | - | - | - | - |
| Net cash flow / Change in cash | 109.8 Million | -321.2 Million | 165.8 Million | 398.2 Million | 1.7 Million | 2.6 Million |
| Free Cash Flow | 261 Million | 580.9 Million | 408 Million | 497.6 Million | 394.3 Million | 261 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 267.6 Million | 132.4 Million | 876.6 Million | 264.6 Million | 258.6 Million | 221 Million |
| Depreciation & Amortization | - | - | 170.7 Million | 41.4 Million | 42.3 Million | 42.1 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | -70.9 Million | - | - | - |
| Other non-cash items | -267.6 Million | -132.4 Million | 456.8 Million | -264.6 Million | -258.6 Million | -221 Million |
| Investing Cash Flow | - | - | -805.7 Million | - | - | - |
| Investments in PPE | - | - | -692.3 Million | - | - | - |
| Acquisitions | - | - | 1.5 Million | - | - | - |
| Investment purchases | - | - | -445.1 Million | - | - | - |
| Sales/Maturities of investments | - | - | 330.2 Million | - | - | - |
| Other Investing Activities | - | - | 154.7 Million | - | - | - |
| Financing Cash Flow | - | - | -198.6 Million | - | - | - |
| Debt repayment | - | - | -100 Thousand | - | - | - |
| Dividends payments | - | - | -198.5 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | -4.5 Million | - | - | - |
| Accounts receivables | - | - | -142.3 Million | - | - | - |
| Accounts payables | - | - | 63.3 Million | - | - | - |
| Inventory | - | - | -59.5 Million | - | - | - |
| Other working capital | - | - | 67.6 Million | - | - | - |
| Cash at beginning of period | - | - | 254.9 Million | 230.1 Million | -28.5 Million | 254.9 Million |
| Cash at end of period | - | - | 364.7 Million | 264.6 Million | 230.1 Million | 221 Million |
| Capital Expenditure | - | - | -692.3 Million | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | 109.8 Million | 34.5 Million | 258.6 Million | -33.9 Million |
| Free Cash Flow | - | - | 261 Million | 264.6 Million | 258.6 Million | 221 Million |
NC6
NETWORK18
8043
CTCL
MSTH
ILTY